Yan Tristan Dongbo, Haveric Namik, Carmignani Carlos Pablo, Bromley Christina M, Sugarbaker Paul H
Program in Peritoneal Surface Malignancy, Washington Cancer Institute, Washington Hospital Center, DC 20010, USA.
Tumori. 2005 Sep-Oct;91(5):394-400. doi: 10.1177/030089160509100503.
Peritoneal mesothelioma is a rare disease with a universally fatal outcome when managed in a traditional palliative manner. New approaches to treatment using cytoreductive surgery and intraperitoneal chemotherapy suggest that long-term survival is possible in selected patients. Early recognition of this disease process with an orderly surgical approach will begin to optimize treatment.
Thirty-three patients with malignant peritoneal mesothelioma had CT scans available for review. A Z-score was used to evaluate the incidence of cancer at a particular anatomic site as compared to a general incidence of disease at all sites. CT was analyzed by abdominopelvic anatomic sites (16), abdominopelvic regions (9), and for presence versus absence of disease in the chest. Interpretative CT findings (class 0-III) were determined for these 33 patients.
Eight of 33 patients had pleural abnormalities. In an analysis of 16 abdominopelvic anatomic sites, the vesical or rectal uterine pouch was involved in 97% and the greater omentum in 91%. These anatomic sites were the only ones with a positive Z-score of >1. In the analysis of 9 abdominopelvic regions, the central and pelvic regions had Z-scores >2 for large volume disease >5 cm. For CT interpretative findings class I, class II and class III was determined in approximately one-third in each category. Sixty-six percent of the patients had ascites by CT.
Malignant peritoneal mesothelioma by CT evaluation predominates in tumor mass within the central and pelvic portions of the abdomen. Minimal, moderate, and extensive small bowel enlargements were seen in roughly one-third of the patients. With the use of the Z-score and interpretative small bowel findings a radiologic characterization of this disease for primary radiologic diagnosis is possible.
腹膜间皮瘤是一种罕见疾病,采用传统姑息治疗方式时预后普遍不良。采用细胞减灭术和腹腔内化疗的新治疗方法表明,部分患者有可能实现长期生存。通过有序的手术方法早期识别该疾病进程将有助于优化治疗。
33例恶性腹膜间皮瘤患者有CT扫描结果可供回顾。Z评分用于评估特定解剖部位的癌症发生率与所有部位疾病的总体发生率相比情况。通过腹盆腔解剖部位(16个)、腹盆腔区域(9个)以及胸部有无疾病对CT进行分析。确定了这33例患者的CT解释性结果(0 - III级)。
33例患者中有8例存在胸膜异常。在对16个腹盆腔解剖部位的分析中,膀胱或直肠子宫陷凹受累率为97%,大网膜受累率为91%。这些解剖部位是仅有的Z评分>1呈阳性的部位。在对9个腹盆腔区域的分析中,中央和盆腔区域对于直径>5 cm的大量疾病Z评分>2。对于CT解释性结果,I级、II级和III级在每个类别中约占三分之一。66%的患者CT显示有腹水。
通过CT评估,恶性腹膜间皮瘤主要表现为腹部中央和盆腔部分的肿瘤肿块。约三分之一的患者可见轻度、中度和广泛的小肠扩张。通过使用Z评分和小肠解释性结果,对该疾病进行原发性放射学诊断的放射学特征描述是可行的。